Stellar/Phunware Release Shareholder Vote Results
by Kristi Marvin on 2019-01-03 at 8:57am

Stellar Acquisition III, now Phunware (PHUN), released the results of their shareholder vote last night and for the most part, the results were unsurprising.  1,813,487 shares of Stellar common stock exercised their right to redeem their shares for cash at a price of $10.64 per share.  This means that approximately $19.3 million was removed from the trust.

If you recall from Stellar’s proxy, there was $19.63 million held in trust as of November 12th, and with an additional month’s worth of interest earned, the total held in trust at combination was most likely closer to $19.7 million.  The press release further goes on to say that as a result of those redemptions, the Stellar trust account had only approximately $0.4 million immediately prior to Closing.

Basically, everyone redeemed.

However, if you look at Phunware’s share price, it’s currently trading at $14.26 and yet, the warrants are trading at $0.30.  Hmmm…that seems to be a major disconnect.  However, the facts are this:  None of the SPAC investors wanted to hold this share post-combination so nearly everyone redeemed. Furthermore, it would appear that none of the capital markets advisors were able to get the shares into the hands of new investors either.  Hence, Stellar kept needing to adjourn the vote until they could bring in the convertible preferred investor for $6.0 million.  Furthermore, if you look at the 8-k, they attached Phunware’s financial statements.   Phunware shows only $5.2 million in revenue for Q3, which is about 30% less than the same quarter in 2017, which showed $7.4 million….very curious indeed.

So if nobody wanted to hold this share pre-vote, how is it magically now worth $14.26 a week later?

There is very little liquidity, and that’s certainly contributing, but who is buying if exactly only one week ago there was zero demand? If something doesn’t make sense, that’s a huge caution sign.  Be careful out there….

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved